This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheralarterydisease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with PeripheralArteryDisease (PAD).
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
However, when these arteries become narrowed or blocked conditions like PeripheralArteryDisease (PAD) can emerge, posing a threat to our overall health. Understanding PeripheralArteryDiseasePeripheralarterydisease or PAD is a condition in which plaque builds up in the arteries that lead to the legs and feet.
It is estimated that more than 10 million Americans are living with PAD, or PeripheralArteryDisease. PAD is a serious condition affecting circulation and blood vessels, causing them to narrow from plaque buildup in the arteries and blocking blood flow to the extremities, typically the legs and feet.
Introduction Statins remain the first-line treatment for secondary prevention of cardiovascular (CV) events, with lowering of low-density lipoprotein cholesterol (LDL-C) being their therapeutic target. Recurrent stroke occurs in up to 19% of patients seven years after a first cerebrovascular event.
The article also includes links to DAIC channels (on peripheralarterydisease, stroke, heart failure, peripheralarterydisease, cardiovascular clinical studies, and more) focused on specific areas of news coverage. 1 in 3 adults with Type 2 diabetes may have undetected cardiovascular disease.
METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.
Raised lipoprotein(a) (Lp[a]) cholesterol is highly prevalent affecting 1 in 5 individuals and is also frequently associated with the inherited condition familial hypercholesterolaemia (FH).
Methods A multicentre cross-sectional epidemiological study to estimate the prevalence of elevated Lp(a) in patients with a history of myocardial infarction, ischaemic stroke or peripheralarterydisease conducted at 949 sites in 48 countries in North America, Europe, Asia, South America, South Africa and Australia between April 2019 and July 2021.
Background and aims Epidemiology of atherosclerotic cardiovascular disease might be different in patients with polygenic hypercholesterolemia plus high levels (≥30 mg/dl) of Lp(a) (H-Lpa) than in those with polygenic hypercholesterolemia alone (H-LDL). The median duration of follow-up was 10 years (IQR 3–16). 3.17, P = 0.006).
According to a recent survey released today by the Society, nearly one in three Americans at the highest risk for developing blood vessel (vascular) diseases have not heard of any of the most common conditions, like peripheralarterydisease and carotid arterydisease.
Specifically: - HDL cholesterol increases by 2–12 mg/dL - Total cholesterol decreases by 8 mg/dL - Triglycerides decrease by 7–13 mg/dL - LDL cholesterol may decrease by 10–13 mg/dL in adults at high cardiometabolic risk Weight and body composition Here’s where resistance exercise shines.
Specifically: - HDL cholesterol increases by 2–12 mg/dL - Total cholesterol decreases by 8 mg/dL - Triglycerides decrease by 7–13 mg/dL - LDL cholesterol may decrease by 10–13 mg/dL in adults at high cardiometabolic risk Weight and body composition Here’s where resistance exercise shines.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
105 
Let's personalize your content